Remove Cooper Remove Development Remove Diversity Remove Pharmaceuticals
article thumbnail

How to Give the Same Talk to Different Audiences

Harvard Business Review

As a professional speaker who delivers between 30-50 paid keynotes per year, here are three strategies I’ve discovered that can help you craft a successful talk that resonates with diverse attendees. First, it can be helpful to envision the sections of your speech as “modules” that you can shift and reshuffle as needed.

article thumbnail

To Innovate in a Big Company, Don’t Think “Us Against Them”

Harvard Business Review

Take the case of Janssen, the pharmaceuticals arm of Johnson & Johnson, which created a breakthrough innovative program called Immersion. The idea started with two Janssen employees, Annick Daems and Enrique Esteban, who were spearheading an initiative to increase the company’s diversity of thought and experience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

India Remakes Global Innovation

Harvard Business Review

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

article thumbnail

The 2010 Execution Round-Up: Six Companies That Couldn't 'Get It.

Strategy Driven

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. The BRIDGE that failed for Gap Makers #2, 3, and 4 : Company-Wide Coordination and Cooperation.